Delamanid-d4

• Description :

  Delamanid-d4 is the deuterium labeled Delamanid. Delamanid, a newer?mycobacterial cell wall synthesis ?inhibitor, inhibits the synthesisi of mucolic acids[1].

• Product Name Alternative :

  OPC-67683-d4

• UNSPSC :

  12352005

• Target :

  Bacterial

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Purity :

  98.44

• Solubility :

  DMF : ≥ 25mg/mL|DMSO : ≥ 20mg/mL

• Smiles :

  FC(F)(F)OC1=CC=C(OC2CCN(C3=C([2H])C([2H])=C(OC[C@@]4(C)CN5C(O4)=NC([N+]([O-])=O)=C5)C([2H])=C3[2H])CC2)C=C1

• Molecular Formula :

  C25H21D4F3N4O6

• Molecular Weight :

  538.51

• References & Citations :

  [1]Sotgiu G, et al. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis. Expert Rev Anti Infect Ther. 2015 Mar;13 (3) :305-15.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported